Viatris (VTRS) Consolidated Net Income (2019 - 2026)

Viatris (VTRS) recorded quarterly Consolidated Net Income of $176.4 million in Q1 2026, up 151.87% quarter-over-quarter from -$340.1 million in Q4 2025, and up 105.8% on a YoY basis from $85.7 million in Q1 2025.

Viatris (VTRS) Consolidated Net Income (2019 - 2026) Analysis & Trends

Viatris' Consolidated Net Income history runs 8 years deep, the most recent figure standing at $176.4 million for Q1 2026.

  • In Q1 2026, Consolidated Net Income rose 105.8% year-over-year to $176.4 million; the TTM figure through Mar 2026 stood at -$296.5 million (up 92.18% YoY), while the FY2025 annual figure was -$3.5 billion, down 454.23% from the prior year.
  • Consolidated Net Income was $176.4 million for Q1 2026 at Viatris, up from -$340.1 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $1.0 billion in Q4 2022 to a low of -$3.0 billion in Q1 2025.
  • Historically, Consolidated Net Income has averaged -$103.7 million across 5 years, with a median of $113.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Consolidated Net Income jumped 483.32% in 2022, then slumped 2770.76% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at $1.0 billion in 2022, then plunged by 175.71% to -$765.6 million in 2023, then surged by 32.54% to -$516.5 million in 2024, then jumped by 34.15% to -$340.1 million in 2025, then jumped by 151.87% to $176.4 million in 2026.
  • The last three Consolidated Net Income figures came in at $176.4 million (Q1 2026), -$340.1 million (Q4 2025), and -$128.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -114,733.81
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Viatris - - 1.16 Bn 176.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 176.40 Mn
Dec 31, 2025 -340.10 Mn
Sep 30, 2025 -128.20 Mn
Jun 30, 2025 -4.60 Mn
Mar 31, 2025 -3.04 Bn
Dec 31, 2024 -516.50 Mn
Sep 30, 2024 94.80 Mn
Jun 30, 2024 -326.40 Mn
Mar 31, 2024 113.90 Mn
Dec 31, 2023 -765.60 Mn
Sep 30, 2023 331.60 Mn
Jun 30, 2023 264.00 Mn
Mar 31, 2023 300.40 Mn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 354.30 Mn
Jun 30, 2022 313.90 Mn
Mar 31, 2022 399.20 Mn
Dec 31, 2021 -263.80 Mn
Sep 30, 2021 311.50 Mn
Jun 30, 2021 -279.20 Mn